Universal Biosensors Inc (UBI) - Total Liabilities
Based on the latest financial reports, Universal Biosensors Inc (UBI) has total liabilities worth AU$7.86 Million AUD (≈ $5.56 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore UBI year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Universal Biosensors Inc - Total Liabilities Trend (2002–2024)
This chart illustrates how Universal Biosensors Inc's total liabilities have evolved over time, based on quarterly financial data. See Universal Biosensors Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Universal Biosensors Inc Competitors by Total Liabilities
The table below lists competitors of Universal Biosensors Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nexera Technologies Ltd.
NASDAQ:NEXR
|
USA | $9.75 Million |
|
MacDonald Mines Exploration Ltd
V:BMK
|
Canada | CA$778.53K |
|
Innovotech Inc
V:IOT
|
Canada | CA$1.05 Million |
|
Metalore Resources Ltd
V:MET
|
Canada | CA$1.02 Million |
|
Colabor Group Inc.
TO:GCL
|
Canada | CA$322.31 Million |
|
Timah Resources Ltd
AU:TML
|
Australia | AU$10.26 Million |
|
Enlitic Inc
AU:ENL
|
Australia | AU$4.24 Million |
|
Cosmo Metals Ltd
AU:CMO
|
Australia | AU$645.80K |
Liability Composition Analysis (2002–2024)
This chart breaks down Universal Biosensors Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Universal Biosensors Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.52 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Universal Biosensors Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Universal Biosensors Inc (2002–2024)
The table below shows the annual total liabilities of Universal Biosensors Inc from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$8.47 Million ≈ $5.99 Million |
-19.07% |
| 2023-12-31 | AU$10.47 Million ≈ $7.40 Million |
-47.81% |
| 2022-12-31 | AU$20.05 Million ≈ $14.19 Million |
+18.70% |
| 2021-12-31 | AU$16.89 Million ≈ $11.95 Million |
-8.21% |
| 2020-12-31 | AU$18.40 Million ≈ $13.02 Million |
+6.60% |
| 2019-12-31 | AU$17.27 Million ≈ $12.22 Million |
-10.56% |
| 2018-12-31 | AU$19.30 Million ≈ $13.66 Million |
-42.36% |
| 2017-12-31 | AU$33.49 Million ≈ $23.70 Million |
-8.83% |
| 2016-12-31 | AU$36.74 Million ≈ $25.99 Million |
+15.90% |
| 2015-12-31 | AU$31.70 Million ≈ $22.43 Million |
+14.05% |
| 2014-12-31 | AU$27.79 Million ≈ $19.66 Million |
+11.45% |
| 2013-12-31 | AU$24.94 Million ≈ $17.64 Million |
+157.21% |
| 2012-12-31 | AU$9.69 Million ≈ $6.86 Million |
-4.90% |
| 2011-12-31 | AU$10.19 Million ≈ $7.21 Million |
+54.01% |
| 2010-12-31 | AU$6.62 Million ≈ $4.68 Million |
+38.78% |
| 2009-12-31 | AU$4.77 Million ≈ $3.37 Million |
-20.29% |
| 2008-12-31 | AU$5.98 Million ≈ $4.23 Million |
+58.18% |
| 2007-12-31 | AU$3.78 Million ≈ $2.68 Million |
+33.42% |
| 2006-12-31 | AU$2.84 Million ≈ $2.01 Million |
+638.35% |
| 2005-12-31 | AU$384.00K ≈ $271.70K |
+48.26% |
| 2004-12-31 | AU$259.00K ≈ $183.26K |
+156.44% |
| 2003-12-31 | AU$101.00K ≈ $71.46K |
-47.40% |
| 2002-12-31 | AU$192.00K ≈ $135.85K |
-- |
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more